J&J Will "Repatriate" Up To $10 Bil. In Foreign-Held Cash If Bill Is Signed
This article was originally published in The Pink Sheet Daily
Executive Summary
Company expects to spend about $350 mil. to $500 mil. to bring the foreign-held cash to U.S.-based accounts. Cash might be used to fund pipeline. J&J continues to work toward achieving $1 bil. annual cost savings.
You may also be interested in...
Bristol Will Repatriate Foreign Cash, Fourth Quarter Charge Expected
Bristol-Myers Squibb intends to take full advantage of a new law allowing companies to repatriate cash held by foreign subsidiaries at a reduced tax rate
Bristol Will Repatriate Foreign Cash, Fourth Quarter Charge Expected
Bristol-Myers Squibb intends to take full advantage of a new law allowing companies to repatriate cash held by foreign subsidiaries at a reduced tax rate
Rx Sales Force Reductions Will Not Impact IMS’ Growth, Company Says
Rx manufacturers are looking to increase the productivity of their sales forces through new segmentation methodologies and more effective promotions, IMS Health exec says. The company sees greater consulting opportunities.